Search Results - "Schwartz, Rowena N"

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update by BASCH, Ethan, PRESTRUD, Ann Alexis, MORROW, Gary, RAO, Kamakshi V, SCHWARTZ, Rowena N, LYMAN, Gary H, HESKETH, Paul J, KRIS, Mark G, FEYER, Petra C, SOMERFIELD, Mark R, CHESNEY, Maurice, CLARK-SNOW, Rebecca Anne, FLAHERTY, Anne Marie, FREUNDLICH, Barbara

“…To update the American Society of Clinical Oncology (ASCO) guideline for antiemetics in oncology. A systematic review of the medical literature was completed…”
Get full text

Anemia in patients with cancer: Incidence, causes, impact, management, and use of treatment guidelines and protocols by Schwartz, Rowena N

“…The incidence, etiology, impact, and considerations in developing guidelines for treating anemia in patients with cancer are described. Anemia is common in…”
Get full text

Multiple myeloma maintenance therapy: A review of the pharmacologic treatment by Shank, Brandon R, Brown, Victoria T, Schwartz, Rowena N

“…Over the last decade, numerous drug therapies have emerged for the treatment of multiple myeloma including immunomodulating agents namely thalidomide,…”
Get full text

Management of early and advanced colorectal cancer: Therapeutic issues by Schwartz, Rowena N

“…The staging of colorectal cancer, therapeutic decision making in the management of early and advanced colorectal cancer, and dilemmas posed by drug-related…”
Get full text

Pharmacists: Integral to the Management of Chemotherapy-Induced Nausea and Vomiting by Jupp, Jennifer, Pasetka, Mark, Soefje, Scott, Schwartz, Rowena N

Get full text

Considerations and challenges with existing treatments for thrombosis in cancer patients by Schwartz, Rowena N

“…One of the standard treatments for cancer-associated thrombosis has been initial therapy with unfractionated heparin (UFH) followed by long-term therapy with…”
Get full text

Cancer- and chemotherapy-induced anemia by Rodgers, 3rd, George M, Becker, Pamela Sue, Blinder, Morey, Cella, David, Chanan-Khan, Asher, Cleeland, Charles, Coccia, Peter F, Djulbegovic, Benjamin, Gilreath, Jeffrey A, Kraut, Eric H, Matulonis, Ursula A, Millenson, Michael M, Reinke, Denise, Rosenthal, Joseph, Schwartz, Rowena N, Soff, Gerald, Stein, Richard S, Vlahovic, Gordana, Weir, 3rd, Alva B

“…Anemia is prevalent in 30% to 90% of patients with cancer. Anemia can be corrected through either treating the underlying cause or providing supportive care…”
Get more information

Management of Venous Thromboembolism for Patients With Hematologic Malignancies by Schwartz, Rowena N

“…Advanced practitioners are an integral part of the cancer care team. Therefore, it is imperative they are knowledgeable of risk factors associated with venous…”
Get full text

Advances in oncology pharmacy practice by SHANK, BRANDON R, SCHWARTZ, ROWENA N, FORTNER, CLARENCE, FINLEY, REBECCA S

Get full text

Managing toxicities of high-dose interleukin-2 by Schwartz, Rowena N, Stover, Lori, Dutcher, Janice P

“…Although high-dose interleukin-2 (IL-2, Proleukin), a highly toxic agent used in the treatment of renal cell carcinoma and melanoma, was initially associated…”
Get more information

Navigating the seasons of survivorship in community oncology by O'Brien, Michele, Stricker, Carrie Tompkins, Foster, Jacqueline D, Ness, Kimberly, Arlen, Aimee Ginsburg, Schwartz, Rowena N

“…Nurses have an important role in the development, implementation, and evaluation of cancer survivorship programs. Growing numbers of cancer survivors challenge…”
Get full text

NCCN Task Force Report: Specialty Pharmacy by Schwartz, Rowena N, Eng, Kirby J, Frieze, Deborah A, Gosselin, Tracy K, Griffith, Niesha, Seung, Amy Hatfield, Hinkel, Jennifer M, Johnson, Philip E, Johnson, Shirley A, Li, Edward C, Szabatura, Audrea Hotsko, Wong, Michael K

“…The use of specialty pharmacies is expanding in oncology pharmacy practice. Specialty pharmacies provide a channel for distributing drugs that, from the payor…”
Get more information

Cancer- and chemotherapy-induced anemia by Rodgers, 3rd, George M, Becker, Pamela Sue, Bennett, Charles L, Cella, David, Chanan-Khan, Asher, Chesney, Carolyn, Cleeland, Charles, Coccia, Peter F, Djulbegovic, Benjamin, Garst, Jennifer L, Gilreath, Jeffrey A, Kraut, Eric H, Lin, Weei-Chin, Matulonis, Ursula, Millenson, Michael, Reinke, Denise, Rosenthal, Joseph, Sabbatini, Paul, Schwartz, Rowena N, Stein, Richard S, Vij, Ravi

Get more information

Chemotherapy-induced nausea and vomiting by Bender, Catherine M, McDaniel, Roxanne W, Murphy-Ende, Kathleen, Pickett, Mary, Rittenberg, Cynthia N, Rogers, Miriam P, Schneider, Susan M, Schwartz, Rowena N

“…Nausea and vomiting (N&V) is among the most distressing side effects of chemotherapy, despite the development of more efficacious antiemetic agents. As many as…”
Get full text

Venous thromboembolism in patients with cancer. Part II. Current treatment strategies by Viale, Pamela Hallquist, Schwartz, Rowena N

“…Patients with cancer have an increased risk of thromboembolism. This complication is connected to a variety of different factors and is influenced by the…”
Get full text

Venous thromboembolism in patients with cancer. Part I. Survey of oncology nurses' attitudes and treatment practices for ambulatory settings by Viale, Pamela Hallquist, Schwartz, Rowena N

“…Patients with cancer have a higher incidence of venous thromboembolism (VTE). Little information currently exists on VTE and the understanding and beliefs of…”
Get full text

Current and emerging treatments for multiple myeloma by Schwartz, Rowena N, Vozniak, Michael

“…The prognosis and treatment of multiple myeloma (MM) has evolved greatly over the past decade. The development and incorporation of new agents such as…”
Get full text

Darbepoetin alfa: a review of its use in patients with cancer by Jung, Laura L, Schwartz, Rowena N

Get more information

Targeted therapies in the treatment of colorectal cancer: what managed care needs to know by Schwartz, Rowena N, Blanke, Charles D, Pesko, Larry John

“…This review is designed to explore the disease, its current treatment, the expanding field of antiangiogenic treatments, and the implications of these advances…”
Get full text

Proceedings of a summit on preventing patient harm and death from i.v. medication errors

Get full text